Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Instashield India is a private Indian health-tech and medical device company developing and manufacturing a virus attenuation device intended to reduce infectivity and transmission of viruses and bacteria in enclosed spaces and on surfaces. The company markets a plug-and-play device that uses electron or negative-ion based technology and has been described in company-related and third-party profiles as validated or certified by organizations including CSIR-CCMB and other testing bodies. Its business appears focused on environmental infection-control equipment rather than therapeutics, with commercialization centered in India and expansion plans that have included manufacturing capacity build-out. Based on available public information, Instashield is best characterized as a medtech/device manufacturer rather than a biotech drug developer, and it does not appear to have a conventional therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InstaShield.